1. Home
  2. SNN vs ALGN Comparison

SNN vs ALGN Comparison

Compare SNN & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$33.44

Market Cap

14.0B

Sector

Health Care

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNN
ALGN
Founded
1856
1997
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
10.2B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
SNN
ALGN
Price
$33.44
$157.47
Analyst Decision
Hold
Buy
Analyst Count
4
13
Target Price
$32.83
$190.50
AVG Volume (30 Days)
476.9K
1.6M
Earning Date
03-02-2026
10-29-2025
Dividend Yield
2.19%
N/A
EPS Growth
59.91
N/A
EPS
0.56
5.16
Revenue
$5,944,000,000.00
$3,982,622,000.00
Revenue This Year
$7.78
$2.58
Revenue Next Year
$5.13
$3.41
P/E Ratio
$29.10
$30.45
Revenue Growth
5.35
0.56
52 Week Low
$23.69
$122.00
52 Week High
$38.79
$246.19

Technical Indicators

Market Signals
Indicator
SNN
ALGN
Relative Strength Index (RSI) 48.01 73.38
Support Level $32.68 $144.00
Resistance Level $33.56 $152.99
Average True Range (ATR) 0.41 4.97
MACD 0.14 1.74
Stochastic Oscillator 78.51 92.40

Price Performance

Historical Comparison
SNN
ALGN

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: